Bullish
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO
Immunic Inc. (NASDAQ: IMUX) has appointed Erik Lundgren, a former Genentech executive with extensive experience in multiple sclerosis, as its new CEO,...